DOA Drugs of Abuse Rapid Test Kit
ANT-120
The DOA Drugs of Abuse Rapid Test Kit delivers fast and reliable screening for common abused drugs including AMP, MET, OPI, THC, COC, and more. Ideal for clinical, workplace, rehabilitation, and community testing. Easy to perform with clear results in minutes — a trusted point-of-care solution for drug abuse detection.
Delivery:
FOB, FCA, DDP
minimum order:
10000 pieces
Supply Ability:
20000pieces / Week
Stock Time:
7Day
Quantity:
Introduction
The DOA Drugs of Abuse Rapid Test Kit is a qualitative in vitro diagnostic device designed for the rapid detection of multiple drugs of abuse and their metabolites in human specimens. Based on colloidal gold immunochromatographic technology, the test provides fast, reliable results without the need for instruments, making it ideal for point-of-care testing (POCT).
Customized Test Items
Single or multi-panel configurations are available upon request. Commonly detected drugs include:
AMP – Amphetamine
MET / MAMP – Methamphetamine
OPI / MOP – Morphine / Opiates
THC – Marijuana
COC – Cocaine
BZO – Benzodiazepines
BAR – Barbiturates
MTD – Methadone
PCP – Phencyclidine
3-panel / 5-panel / 10-panel and customized combinations available
MET / MAMP – Methamphetamine
OPI / MOP – Morphine / Opiates
THC – Marijuana
COC – Cocaine
BZO – Benzodiazepines
BAR – Barbiturates
MTD – Methadone
PCP – Phencyclidine
3-panel / 5-panel / 10-panel and customized combinations available
Specimen Type
Urine (primary)
Other specimen types such as saliva are available upon request
Other specimen types such as saliva are available upon request
Key Features
1. Fast results within 5 minutes
2. Easy operation with no instrument required
3. Clear visual interpretation
4. Multi-drug detection in one test
5. Stable performance and long shelf life
6. OEM / ODM customization available
2. Easy operation with no instrument required
3. Clear visual interpretation
4. Multi-drug detection in one test
5. Stable performance and long shelf life
6. OEM / ODM customization available
This test is based on a competitive immunochromatographic assay. When the drug concentration in the specimen reaches or exceeds the cut-off level, the test line will not appear, indicating a positive result.

